OpenVSafe by OpenVAERS
Search V-safe

EQQ-76133-65639

3 vaccinations 3 coded responses 26 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
605 / IL
Registered
2021-01-23
Relationship
Self
Race
Other
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-01-22
    Dose 1 — Moderna
  2. 2021-01-23
    Registered in v-safe
  3. 2021-01-23
    Survey response — days 1–6 daily, dose 1
    MedDRA: Hyperhidrosis — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Sweating
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2021-01-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  6. 2021-01-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-29
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-05
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-02-12
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-02-25
    Dose 2 — Moderna
  11. 2021-02-25
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  12. 2021-02-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-08-26
    Survey response — 6 months, dose 2
    MedDRA: Abortion spontaneous — Feeling: Good
    Free text: Miscarriage within the first 4 weeks
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  14. 2022-01-15
    Dose 3 — Moderna
  15. 2022-01-15
    Health check-in — day 0, dose 3
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  16. 2022-01-16
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  17. 2022-01-17
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  18. 2022-01-18
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  19. 2022-01-19
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Itching · None
    Adult check-in
  20. 2022-01-20
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  21. 2022-01-21
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  22. 2022-01-22
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  23. 2022-01-29
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  24. 2022-02-07
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  25. 2022-02-12
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  26. 2022-02-21
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  27. 2022-02-28
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  28. 2022-04-16
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  29. 2022-07-16
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  30. 2023-01-15
    Survey response — 12 months, dose 3
    MedDRA: Pregnancy — Feeling: Good
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-01-22Moderna
22021-02-25Moderna
32022-01-15Moderna No

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-23

Systemic reaction (other): Sweating

Release 9 — 6 months, dose 2

2021-08-26

Symptoms: Miscarriage within the first 4 weeks

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbortion spontaneous ✓ · ✓
SDPregnancy · · ✓
SROHyperhidrosis ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…